Insight Molecular Diagnostics Total Current Liabilities 2014-2025 | IMDX
Insight Molecular Diagnostics total current liabilities from 2014 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Insight Molecular Diagnostics Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $7 |
| 2023 | $7 |
| 2022 | $12 |
| 2021 | $14 |
| 2020 | $9 |
| 2019 | $4 |
| 2018 | $6 |
| 2017 | $4 |
| 2016 | $4 |
| 2015 | $2 |
| 2014 | $6 |
| 2013 | $5 |
| Insight Molecular Diagnostics Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-06-30 | $7 |
| 2025-03-31 | $10 |
| 2024-12-31 | $7 |
| 2024-09-30 | $9 |
| 2024-06-30 | $7 |
| 2024-03-31 | $8 |
| 2023-12-31 | $7 |
| 2023-09-30 | $8 |
| 2023-06-30 | $8 |
| 2023-03-31 | $9 |
| 2022-12-31 | $12 |
| 2022-09-30 | $13 |
| 2022-06-30 | $14 |
| 2022-03-31 | $14 |
| 2021-12-31 | $14 |
| 2021-09-30 | $13 |
| 2021-06-30 | $20 |
| 2021-03-31 | $10 |
| 2020-12-31 | $9 |
| 2020-09-30 | $9 |
| 2020-06-30 | $7 |
| 2020-03-31 | $7 |
| 2019-12-31 | $4 |
| 2019-09-30 | $3 |
| 2019-06-30 | $4 |
| 2019-03-31 | $3 |
| 2018-12-31 | $6 |
| 2018-09-30 | $5 |
| 2018-06-30 | $4 |
| 2018-03-31 | $5 |
| 2017-12-31 | $4 |
| 2017-09-30 | $5 |
| 2017-06-30 | $5 |
| 2017-03-31 | $5 |
| 2016-12-31 | $4 |
| 2016-09-30 | $4 |
| 2016-06-30 | $3 |
| 2016-03-31 | $3 |
| 2015-12-31 | $2 |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | $6 |
| 2013-12-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.072B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $43.991B | 53.84 |
| Tempus AI (TEM) | United States | $13.179B | 0.00 |
| Doximity (DOCS) | United States | $12.725B | 56.62 |
| Hims & Hers Health (HIMS) | United States | $9.572B | 78.43 |
| IRhythm Technologies (IRTC) | United States | $5.461B | 0.00 |
| Hinge Health (HNGE) | United States | $4.399B | 0.00 |
| Privia Health (PRVA) | United States | $2.828B | 209.46 |
| Inspire Medical Systems (INSP) | United States | $2.771B | 40.74 |
| Heartflow (HTFL) | $2.557B | 0.00 | |
| Phreesia (PHR) | United States | $1.884B | 0.00 |
| Enovis (ENOV) | United States | $1.766B | 9.34 |
| 10x Genomics (TXG) | United States | $1.744B | 0.00 |
| Omnicell (OMCL) | United States | $1.497B | 28.84 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Clover Health Investments (CLOV) | United States | $1.343B | 0.00 |
| Claritev (CTEV) | United States | $1.135B | 0.00 |
| Evolent Health (EVH) | United States | $1.134B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.679B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.652B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.481B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.405B | 0.00 |
| Carlsmed (CARL) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.53 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.239B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.234B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.175B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| CareCloud (CCLD) | United States | $0.163B | 7.38 |
| American Well (AMWL) | United States | $0.111B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.070B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |